ERBB2 and neoplasm: In both discovery and test cohorts, categorisation of HER2‐positive cases according to HER2 IHC scores, tumours with HER2 IHC3+ showed the highest enrichment of the identified morphometric features and were significantly different from HER2‐positive tumours with borderline protein expression.